Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively affect U.S. patients, here are some of the latest resources to keep in your back pocket:
- Many are concerned about the safety of drugs imported from other countries –our pocket card explains how importation schemes could harm patients.
- Ordering medicine through an online Canadian pharmacy may not be what you think. To better understand the realities of drug importation from Canada, check out our graphic and read our case study on the danger of online pharmacies.
- Another danger of large-scale importation proposals is an increased risk of counterfeit medicines entering the United States. Take a look at these cases of counterfeit cancer drugs entering the United States and counterfeit hepatitis C drugs found in Switzerland.
- Importation schemes won’t just endanger patients – read more about how they would increase the burden on U.S. law enforcement.
- And learn what others are saying – including former commissioners of the U.S. Food and Drug Administration – about these proposals.
Nicole Longo Nicole is senior director of public affairs at PhRMA focusing on Medicare, 340B, importation and more. She previously worked for a D.C.-based public affairs firm where she assisted a wide range of clients with communications efforts on everything from trade policy to agriculture policy to health care policy. Outside the office, Nicole can be found trying new restaurants (usually Italian), taking an occasional barre class and cheering on the Cincinnati Bengals.